PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsInsulin aspart
Novolog, Novorapid(insulin aspart)
Fiasp, Insulin Aspart, Kirsty, Kixelle, Mix, NovoRapid, Novolog, Novolog Mix, Ryzodeg (insulin aspart) is a protein pharmaceutical. Insulin aspart was first approved as Novorapid on 1999-09-07. It has been approved in Europe to treat diabetes mellitus.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nutritional and metabolic diseasesD009750
endocrine system diseasesD004700
Trade Name
FDA
EMA
Fiasp, Novolog (discontinued: Novolog)
Combinations
Novolog mix (discontinued: Novolog mix, Ryzodeg)
Drug Products
FDA
EMA
Reference product - 351(a)
Reference product - 351(a)
Interchangeable product - 351(k)
Interchangeable product - 351(k)
Biosimilar product - 351(k)
Biosimilar product - 351(k)
Insulin aspart
Tradename
Proper name
Company
Number
Date
Products
Fiaspinsulin aspartNovo NordiskN-208751 RX2017-09-29
4 products
Novologinsulin aspartNovo NordiskN-20986 RX2000-06-07
3 products
Show 1 discontinued
Insulin aspart
+
Insulin aspart protamine
Tradename
Proper name
Company
Number
Date
Products
Novolog Mix 70/30insulin aspart protamine and insulin aspartNovo NordiskN-21172 RX2001-11-01
2 products
Show 2 discontinued
Insulin aspart
+
Insulin degludec
Tradename
Proper name
Company
Number
Date
Products
Ryzodeg 70/30insulin degludec and insulin aspartNovo NordiskN-203313 DISCN2015-09-25
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
.insulin aspart protamine and insulin aspartBiologic Licensing Application2024-02-22
.insulin aspart protamine and insulin aspart insulin aspart protamine and insulin aspartBiologic Licensing Application2019-11-15
adderallNew Drug Application2025-03-13
adderall xrNew Drug Application2010-03-29
aminosyn iiNew Drug Application2022-05-04
aminosyn-pfNew Drug Application2022-07-21
chromagenunapproved drug other2024-01-23
clinisolANDA2018-06-01
dextroamphetamine saccharate and amphetamine aspartate and dextroamphetamine sulfate and amphetamine sulfateANDA2023-10-20
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfateANDA2025-03-17
Show 33 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
A10: Drugs used in diabetes
A10A: Insulins and analogues
A10AB: Insulins and analogues for injection, fast-acting
A10AB05: Insulin aspart
A10AD: Insulins and analogues for injection used in diabetes, intermediate- or long-acting combined with fast-acting
A10AD05: Insulin aspart
A10AD06: Insulin degludec and insulin aspart
HCPCS
No data
Clinical
Clinical Trials
605 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diabetes mellitusD003920EFO_0000400E08-E1366618
Type 2 diabetes mellitusD003924EFO_0001360E1113711
Type 1 diabetes mellitusD003922EFO_0001359E10433111
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HyperglycemiaD006943R73.911
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameInsulin aspart
INNinsulin aspart
Description
Insulin aspart
Classification
Protein
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL1201496
ChEBI ID
PubChem CID
DrugBankDB01306
UNII IDD933668QVX (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
£
Ryzodeg Novo Nordisk
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Novorapid Novo Nordisk
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Novomix Novo Nordisk
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Fiasp Novo Nordisk
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Insulin aspart
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 5,782 documents
View more details
Safety
Black-box Warning
Black-box warning for: Adderall, Adderall xr, Aminosyn ii, Chromagen, Dextroamphetamine saccharate and amphetamine aspartate and dextroamphetamine sulfate and amphetamine sulfate, Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate, Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate, Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate extended-release, Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate, Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-release, Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate, Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate, Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate tablets,cii, Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate, Mixed salts of a single entity amphetamine product, Mixed salts of a single-entity amphetamine product, Mydayis, Niferex, Prenate dha, Prenate elite, Prenate essential, Prenate mini, Prenate pixie, Primacare
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
44,400 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use